YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
2.350
-0.070 (-2.89%)
At close: Jun 26, 2026, 4:00 PM EDT
2.200
-0.150 (-6.38%)
After-hours: Jun 26, 2026, 4:59 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $165.25 million as of June 26, 2026. Its market cap has increased by 293.46% in one year.
Market Cap
165.25M
Enterprise Value
162.14M
1-Year Change
293.46%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $165.25M, an increase of 11.39%. That is a compound annual growth rate of 1.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 165.25M | -80.72% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 175.49M |
| Acumen Pharmaceuticals | 170.46M |
| Milestone Pharmaceuticals | 168.70M |
| Innate Pharma | 168.65M |
| Caribou Biosciences | 166.62M |
| Kazia Therapeutics | 162.49M |
| Corbus Pharmaceuticals Holdings | 161.93M |
| ProQR Therapeutics | 161.20M |